Zim Laboratories

{
  "main_header": {
    "sid": 1000979,
    "name": "Zim Laboratories",
    "stock_name": "Zim Laboratories",
    "full_name": "Zim Laboratories Ltd",
    "name_url": "stocks-analysis/zim-laboratories",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "79.01",
    "chg": -0.53,
    "chgp": "-0.67%",
    "dir": -1,
    "prev_price": "79.54",
    "mcapval": "387.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 541400,
    "symbol": "ZIMLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE518E01015",
    "curr_date": "Jan 19",
    "curr_time": "",
    "bse_nse_vol": "69.97 k",
    "exc_status": "Active",
    "traded_date": "Jan 19, 2026",
    "traded_date_str": "2026 01 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/zim-laboratories-1000979-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Zim Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zim-laboratories-ltd-is-rated-strong-sell-3791891",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ZimLaboratories_mojoScore_3791891.png",
        "date": "2026-01-14 10:10:21",
        "description": "Zim Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 14 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Zim Laboratories Ltd Stock Hits 52-Week Low Amidst Continued Financial Pressures",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zim-laboratories-ltd-stock-hits-52-week-low-amidst-continued-financial-pressures-3791078",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ZimLaboratories_priceRelatedfactors_3791078.png",
        "date": "2026-01-12 13:03:57",
        "description": "Zim Laboratories Ltd has touched a new 52-week low of Rs.64.1 today, marking a significant decline in its stock price amid ongoing financial pressures and subdued performance metrics. Despite a modest recovery over the past two days, the stock remains considerably below its previous highs and continues to trail behind sector benchmarks."
      },
      {
        "title": "Zim Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zim-laboratories-ltd-is-rated-strong-sell-3780009",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/ZimLaboratories_mojoScore_3780009.png",
        "date": "2026-01-03 10:10:05",
        "description": "Zim Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 August 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed below represent the stock's current position as of 03 January 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Why is Zim Laboratories Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-zim-laboratories-ltd-fallingrising-3771735",
        "imagepath": "",
        "date": "2025-12-27 00:45:57",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Extended Underperformance Against Benchmarks</strong></p>\n<p>Examining the stock’s returns relative to the Sensex reveals a stark contrast. Over the past week, Zim Laboratories has declined by 4.22%, while the Sensex marginally gained 0.13%. The one-month performance shows a 5.03% drop for the stock against a 0.66% decline in the benchmark. More strikingly, the year-to-date (YTD) return for Zim Laboratories stands at a steep negative 36.78%, whereas the Sensex has appreciated by 8.83%. This divergence extends over longer horizons as well, with the stock down by over 39% in the last year compared to an 8.37% gain in the Sensex, and a 36.92% fall over three years against a robust 40.41% rise in the benchmark. Even over five years, the stock has declined by 25.25%, while the Sensex surged by 81..."
      },
      {
        "title": "Zim Laboratories Sees Revision in Market Evaluation Amidst Challenging Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zim-laboratories-downgraded-to-strong-sell-amid-weak-fundamentals-and-negative-financial-trends-3767037",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ZimLaboratories_mojoScore_3767037.png",
        "date": "2025-12-23 10:10:16",
        "description": "Zim Laboratories, a microcap player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its market evaluation metrics reflecting ongoing challenges in its financial and operational performance. This shift highlights the company’s current standing amid a backdrop of subdued profitability and persistent negative results."
      },
      {
        "title": "Zim Laboratories Sees Revision in Market Assessment Amidst Challenging Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zim-laboratories-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-trends-3741304",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ZimLaboratories_mojoScore_3741304.png",
        "date": "2025-12-02 10:09:20",
        "description": "Zim Laboratories, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. The stock has faced persistent headwinds, with recent assessment changes highlighting concerns across multiple performance parameters."
      },
      {
        "title": "Zim Laboratories Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zim-laboratories-faces-extreme-selling-pressure-amid-lower-circuit-lockdown-3733050",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ZimLaboratories_only_sellers_3733050.png",
        "date": "2025-11-27 09:51:01",
        "description": "Zim Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, is currently experiencing severe selling pressure with no buyers in the queue, signalling distress selling and a challenging market environment for the stock."
      },
      {
        "title": "Zim Laboratories Faces Selling Pressure with Year-to-Date Losses of 31.56% Amid Declines",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zim-laboratories-faces-selling-pressure-with-year-to-date-losses-of-3156-amid-declines-3706593",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ZimLaboratories_only_sellers_3706593.png",
        "date": "2025-11-17 09:31:19",
        "description": "Zim Laboratories Ltd is experiencing significant selling pressure, marked by consecutive days of losses. While it has shown a modest weekly gain, its longer-term performance is troubling, with notable declines over three months, year-to-date, and the past year, reflecting broader market trends and potential company-specific challenges."
      },
      {
        "title": "Zim Laboratories Faces Financial Challenges Amidst Mixed Market Performance Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zim-laboratories-financial-trend-improves-from-very-negative-to-negative-despite-ongoing-challenges-3701291",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ZimLaboratories_fintrenddot_3701291.png",
        "date": "2025-11-14 11:03:00",
        "description": "Zim Laboratories has reported a challenging financial quarter ending September 2025, with significant declines in profit before tax and profit after tax. Key metrics show low return on capital employed and reduced cash reserves, alongside a rising debt-equity ratio, indicating heightened financial concerns amid mixed market performance."
      }
    ],
    "total": 489,
    "sid": "1000979",
    "stock_news_url": "https://www.marketsmojo.com/news/zim-laboratories-1000979"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "21 Jan 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Zim Laboratories Ltd has declared <strong>5%</strong> dividend, ex-date: 19 Sep 19",
          "dt": "2019-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Zim Laboratories Ltd has announced <strong>2:1</strong> bonus issue, ex-date: 22 Dec 22",
          "dt": "2022-12-22",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Zim Laboratories Ltd is Rated Strong Sell

2026-01-14 10:10:21

Zim Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 14 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Zim Laboratories Ltd Stock Hits 52-Week Low Amidst Continued Financial Pressures

2026-01-12 13:03:57

Zim Laboratories Ltd has touched a new 52-week low of Rs.64.1 today, marking a significant decline in its stock price amid ongoing financial pressures and subdued performance metrics. Despite a modest recovery over the past two days, the stock remains considerably below its previous highs and continues to trail behind sector benchmarks.

Read full news article

Zim Laboratories Ltd is Rated Strong Sell

2026-01-03 10:10:05

Zim Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 August 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed below represent the stock's current position as of 03 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Why is Zim Laboratories Ltd falling/rising?

2025-12-27 00:45:57

Extended Underperformance Against Benchmarks

Examining the stock’s returns relative to the Sensex reveals a stark contrast. Over the past week, Zim Laboratories has declined by 4.22%, while the Sensex marginally gained 0.13%. The one-month performance shows a 5.03% drop for the stock against a 0.66% decline in the benchmark. More strikingly, the year-to-date (YTD) return for Zim Laboratories stands at a steep negative 36.78%, whereas the Sensex has appreciated by 8.83%. This divergence extends over longer horizons as well, with the stock down by over 39% in the last year compared to an 8.37% gain in the Sensex, and a 36.92% fall over three years against a robust 40.41% rise in the benchmark. Even over five years, the stock has declined by 25.25%, while the Sensex surged by 81...

Read full news article

Zim Laboratories Sees Revision in Market Evaluation Amidst Challenging Fundamentals

2025-12-23 10:10:16

Zim Laboratories, a microcap player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its market evaluation metrics reflecting ongoing challenges in its financial and operational performance. This shift highlights the company’s current standing amid a backdrop of subdued profitability and persistent negative results.

Read full news article

Zim Laboratories Sees Revision in Market Assessment Amidst Challenging Fundamentals

2025-12-02 10:09:20

Zim Laboratories, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. The stock has faced persistent headwinds, with recent assessment changes highlighting concerns across multiple performance parameters.

Read full news article

Zim Laboratories Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-27 09:51:01

Zim Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, is currently experiencing severe selling pressure with no buyers in the queue, signalling distress selling and a challenging market environment for the stock.

Read full news article

Zim Laboratories Faces Selling Pressure with Year-to-Date Losses of 31.56% Amid Declines

2025-11-17 09:31:19

Zim Laboratories Ltd is experiencing significant selling pressure, marked by consecutive days of losses. While it has shown a modest weekly gain, its longer-term performance is troubling, with notable declines over three months, year-to-date, and the past year, reflecting broader market trends and potential company-specific challenges.

Read full news article

Zim Laboratories Faces Financial Challenges Amidst Mixed Market Performance Trends

2025-11-14 11:03:00

Zim Laboratories has reported a challenging financial quarter ending September 2025, with significant declines in profit before tax and profit after tax. Key metrics show low return on capital employed and reduced cash reserves, alongside a rising debt-equity ratio, indicating heightened financial concerns amid mixed market performance.

Read full news article

View All News